ResMed Debt to Equity Ratio 2006-2018 | RMD

Current and historical debt to equity ratio values for ResMed (RMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ResMed debt/equity for the three months ending September 30, 2018 was 0.27.
ResMed Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.52B $1.90B 0.27
2018-06-30 $0.27B $2.06B 0.13
2018-03-31 $0.81B $2.07B 0.39
2017-12-31 $0.00B $2.02B 0.00
2017-09-30 $1.02B $2.05B 0.50
2017-06-30 $1.08B $1.96B 0.55
2017-03-31 $1.17B $1.86B 0.63
2016-12-31 $0.87B $1.71B 0.51
2016-09-30 $0.87B $1.77B 0.49
2016-06-30 $0.87B $1.70B 0.52
2016-03-31 $0.44B $1.67B 0.26
2015-12-31 $0.40B $1.52B 0.26
2015-09-30 $0.50B $1.46B 0.34
2015-06-30 $0.30B $1.59B 0.19
2015-03-31 $0.46B $1.54B 0.30
2014-12-31 $0.45B $1.59B 0.28
2014-09-30 $0.38B $1.65B 0.23
2014-06-30 $0.30B $1.76B 0.17
2014-03-31 $0.40B $1.69B 0.23
2013-12-31 $0.44B $1.64B 0.27
2013-09-30 $0.00B $1.69B 0.00
2013-06-30 $0.00B $1.61B 0.00
2013-03-31 $0.00B $1.77B 0.00
2012-12-31 $0.30B $1.75B 0.17
2012-09-30 $0.27B $1.70B 0.16
2012-06-30 $0.25B $1.61B 0.16
2012-03-31 $0.24B $1.61B 0.15
2011-12-31 $0.23B $1.56B 0.14
2011-09-30 $0.13B $1.55B 0.08
2011-06-30 $0.10B $1.73B 0.06
2011-03-31 $0.08B $1.66B 0.05
2010-12-31 $0.00B $1.61B 0.00
2010-09-30 $0.00B $1.48B 0.00
2010-06-30 $0.00B $1.29B 0.00
2010-03-31 $0.03B $1.33B 0.02
2009-12-31 $0.10B $1.26B 0.08
2009-09-30 $0.10B $1.20B 0.08
2009-06-30 $0.09B $1.12B 0.08
2009-03-31 $0.09B $0.97B 0.10
2008-12-31 $0.09B $0.96B 0.09
2008-09-30 $0.11B $0.97B 0.11
2008-06-30 $0.09B $1.08B 0.09
2008-03-31 $0.12B $1.07B 0.11
2007-12-31 $0.11B $1.02B 0.11
2007-09-30 $0.09B $0.98B 0.09
2007-06-30 $0.09B $0.93B 0.09
2007-03-31 $0.10B $0.87B 0.11
2006-12-31 $0.10B $0.85B 0.11
2006-09-30 $0.12B $0.77B 0.15
2006-06-30 $0.12B $0.74B 0.16
2006-03-31 $0.09B $0.67B 0.14
2005-12-31 $0.06B $0.53B 0.11
2005-09-30 $0.06B $0.51B 0.12
2005-06-30 $0.06B $0.47B 0.12
2005-03-31 $0.11B $0.46B 0.24
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.846B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.35
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Bovie Medical (BVX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
InfuSystems Holdings (INFU) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00